Skip to main content
. 2023 Feb 13;23:90. doi: 10.1186/s12879-023-08054-w

Table 2.

Descriptive characteristics of overall participants and by SBP trajectory

Variables Overall Class1 Class2 Class3 Class4 Class5 Class6 Class7 P-value
Number 3034 1121 227 255 646 463 248 86
Age 67 (56, 77) 66 (55, 77) 66 (57, 78) 69 (57, 78) 68 (57, 79) 67 (56, 77) 67 (56, 78) 66 (56, 76) 0.2
Gender 0.049
 Male 1,725 (57%) 648 (58%) 137 (60%) 151 (59%) 364 (57%) 240 (52%) 128 (52%) 57 (66%)
 Female 1,309 (43%) 469 (42%) 90 (40%) 103 (41%) 277 (43%) 223 (48%) 118 (48%) 29 (34%)
Heart rate (beats/min) (h) 91 (79,104) 93 (79,106) 94 (81, 109) 88 (76, 100) 89 (77, 101) 91 (80, 103) 89 (78, 103) 88 (78, 102)  < 0.001
SBP (mmHg) 108 (101, 118) 105 (99, 112) 98 (90, 105) 121 (111, 135) 112 (105, 122) 108 (102, 115) 114 (106, 125) 125 (113, 145)  < 0.001
DBP (mmHg) 58 (52, 64) 58 (52, 63) 55 (50, 59) 61 (54, 69) 58 (52, 65) 58 (52, 64) 59 (53, 64) 63 (54, 70)  < 0.001
Respiration rate (beats/min) 20.3 (17.6, 23.7) 20.6 (17.7, 24.0) 21.2 (17.9, 25.1) 19.4 (17.0, 22.9) 20.3 (17.5, 23.1) 20.4 (17.8, 23.7) 19.6 (17.2, 23.3) 19.0 (16.7, 22.2)  < 0.001
Temperature (℃) (T) 36.84 (36.48, 37.26) 36.84 (36.44, 37.28) 36.75 (36.20, 37.25) 36.92 (36.60, 37.28) 36.83 (36.49, 37.23) 36.84 (36.50, 37.28) 36.87 (36.58, 37.24) 37.06 (36.57, 37.36) 0.026
SpO2 (%) 97.05 (95.50, 98.50) 96.88 (95.32, 98.34) 96.50 (94.88, 97.96) 97.21 (95.72, 98.62) 97.29 (95.77, 98.59) 96.92 (95.31, 98.53) 97.57 (96.04, 98.71) 97.72 (96.32, 99.13)  < 0.001
AST (U/l) 39 (23, 85) 38 (24, 92) 52 (28, 129) 42 (23, 90) 37 (23, 70) 38 (24, 85) 40 (22, 85) 36 (19, 51)  < 0.001
Albumin (g/dl) 2.90 (2.40, 3.40) 2.90 (2.40, 3.40) 2.80 (2.30, 3.30) 3.30 (2.80, 3.70) 2.80 (2.40, 3.30) 2.80 (2.40, 3.30) 3.20 (2.50, 3.60) 3.40 (3.00, 3.90)  < 0.001
Bicarbonate (mmol/l) 24 (21, 27) 24 (21, 27) 24 (19, 26) 24 (21, 27) 24 (20, 27) 24 (21, 27) 24 (20, 26) 24 (21, 26) 0.3
Neutrophils (%) 80 (68, 87) 81 (69, 88) 79 (63, 87) 78 (63, 85) 80 (68, 87) 79 (65, 86) 84 (71, 90) 86 (78, 91)  < 0.001
PLT (K/µl) 210 (148, 296) 216 (152, 300) 197 (127, 276) 187 (130, 254) 218 (158, 303) 208 (144, 293) 219 (142, 300) 212 (172, 282)  < 0.001
INR 1.30 (1.10, 1.80) 1.30 (1.10, 1.80) 1.50 (1.20, 2.45) 1.20 (1.10, 1.40) 1.20 (1.10, 1.60) 1.40 (1.20, 2.10) 1.20 (1.10, 1.60) 1.25 (1.10, 1.60)  < 0.001
WBC (× 10^9/l) 9 (6, 14) 10 (6, 15) 8 (6, 14) 9 (6, 14) 9 (6, 13) 9 (6, 14) 8 (6, 12) 7 (4, 9)  < 0.001
CK (U/l) 117 (40, 354) 128 (42, 414) 130 (53, 454) 81 (36, 273) 113 (43, 401) 113 (39, 354) 101 (37, 328) 78 (30, 319) 0.042
CK-MB (U/l) 5 (3, 10) 5 (3, 10) 5 (3, 10) 5 (3, 9) 5 (3, 9) 5 (3, 10) 5 (3, 10) 5 (3, 10) 0.4
Creatinine (µmol/l) 1.20 (0.80, 2.10) 1.20 (0.80, 2.10) 1.50 (1.00, 2.95) 1.10 (0.70, 1.80) 1.20 (0.80, 2.10) 1.10 (0.80, 1.85) 1.00 (0.70, 1.60) 1.40 (0.90, 2.80)  < 0.001
Glucose (mg/dl) 126 (98, 166) 114 (95, 151) 130 (100, 172) 137 (106, 190) 137 (101, 193) 110 (83, 146) 134 (102, 183) 288 (162, 550)  < 0.001
Lymphocyte count (× 10^9/l) 11 (6, 19) 10 (6, 18) 13 (9, 22) 13 (8, 24) 10 (6, 18) 12 (7, 21) 9 (5, 18) 7 (4, 11)  < 0.001
Na (mmol/l) 138 (135, 141) 138 (135, 141) 138 (135, 140) 137 (134, 140) 139 (136, 141) 139 (135, 142) 138 (135, 141) 138 (136, 140)  < 0.001
Congestive heart failure, n (%) 0.2
 Yes 934 (31%) 358 (32%) 81 (36%) 74 (29%) 201 (31%) 137 (30%) 62 (25%) 21 (24%)
 No 2,100 (69%) 759 (68%) 146 (64%) 180 (71%) 440 (69%) 326 (70%) 184 (75%) 65 (76%)
Cerebrovascular disease, n (%) 0.009
 Yes 290 (9.6%) 88 (7.9%) 13 (5.7%) 27 (11%) 75 (12%) 44 (9.5%) 29 (12%) 14 (16%)
 No 2,744 (90%) 1,029 (92%) 214 (94%) 227 (89%) 566 (88%) 419 (90%) 217 (88%) 72 (84%)
Chronic pulmonary disease, n (%) 0.5
 Yes 843 (28%) 314 (28%) 65 (29%) 78 (31%) 182 (28%) 124 (27%) 55 (22%) 25 (29%)
 No 2,191 (72%) 803 (72%) 162 (71%) 176 (69%) 459 (72%) 339 (73%) 191 (78%) 61 (71%)